# Corbus Pharmaceuticals Holdings, Inc.: Form 8-K, filed May 20, 2024

- Company: [Corbus Pharmaceuticals Holdings, Inc.](/companies/crbp.md) (CIK 1595097)
- Form: 8-K
- Filed: 2024-05-20
- Accepted by EDGAR: May 20, 2024, 16:30 ET
- Period: 2024-05-16
- Accession: 0000950170-24-062436
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1595097/000095017024062436/crbp-20240516.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1595097/000095017024062436/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1595097/000095017024062436/crbp-20240516.htm

Filed May 20, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-062436. Last ingested by Listed: Nov 2, 2026, 16:32 ET. No prices; not investment advice.